Ionis Pharmaceuticals
(IONS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,812 | -10,783 | -1,616 | 5,878 | 8,964 |
| Depreciation Amortization | 12,522 | 51,296 | 40,405 | 27,662 | 13,558 |
| Accounts receivable | 26,097 | 45,088 | 65,119 | 57,428 | 38,686 |
| Accounts payable and accrued liabilities | -13,144 | 1,784 | -1,707 | -10,030 | 472 |
| Other Working Capital | -17,171 | 37,044 | 44,405 | 49,563 | 79,512 |
| Other Operating Activity | 15,673 | 49,720 | 7,142 | -5,473 | -18,527 |
| Operating Cash Flow | $13,165 | $174,149 | $153,748 | $125,028 | $122,665 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 82,567 | -320,441 | -275,795 | -145,441 | -166,962 |
| PPE Investments | -2,343 | -34,764 | -26,502 | -9,453 | -3,237 |
| Purchase Of Investment | N/A | -2,500 | N/A | N/A | N/A |
| Sale Of Investment | N/A | 2,507 | 2,507 | 2,507 | 2,507 |
| Purchase Sale Intangibles | -738 | -3,093 | -4,289 | -1,593 | -983 |
| Other Investing Activity | -738 | -3,093 | -4,289 | -1,593 | -983 |
| Investing Cash Flow | $79,486 | $-358,291 | $-304,079 | $-153,980 | $-168,675 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 59,750 | 59,750 | N/A | N/A |
| Debt Repayment | N/A | -3,599 | -3,577 | -3,278 | -1,640 |
| Common Stock Issued | 5,675 | 255,106 | 249,847 | 81,567 | 77,964 |
| Other Financing Activity | -451 | -82,170 | -81,190 | -1,031 | -778 |
| Financing Cash Flow | $5,224 | $229,087 | $224,830 | $77,258 | $75,546 |
| Beginning Cash Position | 129,630 | 84,685 | 84,685 | 84,685 | 84,685 |
| End Cash Position | 227,505 | 129,630 | 159,184 | 132,991 | 114,221 |
| Net Cash Flow | $97,875 | $44,945 | $74,499 | $48,306 | $29,536 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,165 | 174,149 | 153,748 | 125,028 | 122,665 |
| Capital Expenditure | -2,343 | -34,764 | -26,502 | -9,453 | -3,237 |
| Free Cash Flow | 10,822 | 139,385 | 127,246 | 115,575 | 119,428 |